ONM-501

ONM-501 · OncoNano Medicine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONM-501, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. [Phase 1]

See pricing